Control of blood pressure in hypertensive neurological emergencies

Current Hypertension Reports

Volumn 16, Issue 6, 2014, Pages

  Manning, Lisa ^a   Robinson, Thompson G ^a   Anderson, Craig S ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Critical care; Emergencies; Encephalopathy; Hypertension; Intracerebral hemorrhage; Neurological; Stroke; Subarachnoid hemorrhage

Indexed keywords

CLEVIDIPINE; ENALAPRILAT; ESMOLOL; GLYCERYL TRINITRATE; LABETALOL; NICARDIPINE; NITROPRUSSIDE SODIUM; URAPIDIL; ANTIHYPERTENSIVE AGENT;

AUTOREGULATION; BLOOD BRAIN BARRIER; BLOOD PRESSURE REGULATION; BRAIN BLOOD FLOW; BRAIN CIRCULATION; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PERFUSION; CAUSE OF DEATH; CEREBRAL AUTOREGULATION; CEREBROVASCULAR ACCIDENT; COMPARATIVE EFFECTIVENESS; EMERGENCY CARE; HUMAN; HYPERTENSION ENCEPHALOPATHY; MEAN ARTERIAL PRESSURE; REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME; REVIEW; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW; BLOOD PRESSURE MEASUREMENT; CEREBRAL HEMORRHAGE; COMPLICATION; CRITICAL ILLNESS; DRUG COMBINATION; EMERGENCY; FEMALE; HYPERTENSION; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MORTALITY; NERVOUS SYSTEM DISEASES; PATHOPHYSIOLOGY; PROCEDURES; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; STROKE; SURVIVAL;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; CEREBRAL HEMORRHAGE; CRITICAL CARE; CRITICAL ILLNESS; DRUG THERAPY, COMBINATION; EMERGENCIES; FEMALE; HUMANS; HYPERTENSION; INFUSIONS, INTRAVENOUS; MALE; NERVOUS SYSTEM DISEASES; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; STROKE; SUBARACHNOID HEMORRHAGE; SURVIVAL ANALYSIS;

EID: 84901730036     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-014-0436-x     Document Type: Review

References (106)

1. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206-52. (Pubitemid 37553153)
2. • Peacock IVWF, Hilleman DE, Levy PD, Rhoney DH, Varon J. A systematic review of nicardipine vs labetalol for the management of hypertensive crises. Am J Emerg Med. 2012;30(6):981-93. A recent systematic review of treatment in hypertensive crises. The results of this review show comparable efficacy and safety for nicardipine and labetalol, although nicardipine appears to provide more predictable and consistent BP control than labetalol. In a number of included studies there was a theme of a relative lack of awareness among health care professionals regarding the use of nicardipine in patients with stroke, despite its inclusion in AHA/ ASA guidelines, and authors suggest a requirement for education regarding the appropriate use and the approved indications of the drug.
3. Papadopoulus D, Lordanis M, Thomopoulos C, Makris T, et al. Hypertension crisis. Blood Press. 2010;19:328-36.
4. Zampaglione B, Pascale C, Marchisio M, Cavallo-Perin P. Hypertensive urgencies and emergencies: prevalence and clinical presentation. Hypertension. 1996;27(1):144-7. (Pubitemid 26017693)
5. Martin JFV, Higashiama E, Garcia E, et al. Hypertensive crisis profile. Prevelence and clinical presentation. Arq Bras Cardiol. 2004;83:131-6.
6. Bennett NM, Shea S. Hypertensive emergency: case criteria, sociodemographic profile and previous care of 100 cases. Am J Public Health. 1988;78:636-40.
7. Varon J. Treatment of acute hypertension: current and newer agents. Drugs. 2008;68:283-97. (Pubitemid 351225810)
8. Mancia G, Fagard R, Narkiewicz K, et al. 2013 practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC task force for the management of arterial hypertension. J Hypertens. 2013;31(10):1925-38.
9. Paulson OB, Strandgaard S, Edvinson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev. 1990;2:161-92.
10. Symon L, Held K, Dorsch NWC. A study of regional autoregulation in the cerebral circulation to increased perfusion pressure in normocapnia and hypercapnia. Stroke. 1973;4(2):139-47.
11. Rose JC, Mayer SA. Optimizing blood pressure in neurologic emergencies. Neurocrit Care. 2004;1:287-99. (Pubitemid 41278343)
12. Dawson SL, Panerai R, Potter J. Serial changes in static and dynamic cerebral autoregulation after acute ischaemic stroke. Cerebrovasc Dis. 2003;16:69-75. (Pubitemid 36676999)
13. Aries MJH, Elting JW, De Keyser J, Kremer BPH, Vroomen PCAJ. Cerebral autoregulation in stroke: a review of transcranial doppler studies. Stroke. 2010;41(11):2697-704.
14. Yamamoto S, Nishizawa S, Tsukada H, et al. Cerebral blood flow autoregulation following subarachnoid hemorrhage in rats: chronic vasospasm shifts the upper and lower limits of the autoregulatory range toward higher blood pressures. Brain Res. 1998;782(1-2):194-201. (Pubitemid 28122994)
15. Strangaard S, Paulson OB. Cerebral blood flow and its pathophysiology in hypertension. Am J Hypertens. 1989;6:486-92. (Pubitemid 19168237)
16. Qureshi AI. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation. 2008;118(2):176-87.
17. Morgenstern LB, Hemphill JC, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke. 2010;41(9):2108-29.
18. The Brain Trauma Foundation. Guidelines for cerebral perfusion pressure. J Neurotrauma. 2000;17:507-11.
19. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of diseases study 2010. Lancet. 2012;380(9859):2095-128.
20. International Stroke Trial Collaborative Group. The international stroke trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. Lancet. 1997;349(9065):1569-81.
21. Qureshi AI, Ezzeddine MA, Nasar A, Suri MF, Kirmani JF, Hussein HM. Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med. 2007;25:32-8. (Pubitemid 44869006)
22. Ahmed N, Wahlgren N, Brainin M, Castillo J, Ford GA, Kaste M, et al. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis. Retrospective analysis from safe implementation of thrombolysis in stroke-international stroke thrombolysis register (SITS-ISTR). Stroke. 2009;40:2442-9.
23. Robinson T. The predictive role of 24-hour compared to casual blood pressure levels on outcome following acute stroke. Cerebrovasc Dis. 1997;7:264-72. (Pubitemid 27443202)
24. Dawson SL, Manktelow BN, Robinson TG, Panerai RB, Potter JF. Which parameters of beat-to-beat blood pressure and variability best predict early outcome after acute ischemic stroke? Stroke. 2000;31(2):463-8. (Pubitemid 30078183)
25. Ahmed N, Wahlgren N. High initial blood pressure after acute stroke is associated with poor functional outcome. J Intern Med. 2001;249:467-73. (Pubitemid 34208951)
26. Leonardi-Bee J, Bath PMW, Phillips SJ, Sandercock PAG, for the IST Collaborative Group. Blood pressure and clinical outcomes in the international stroke trial. Stroke. 2002;33(5):1315-20. (Pubitemid 34517053)
27. Aslanyan S, Fazekas F, Weir CJ, Horner S, Lees KR. GAIN international steering committee and investigators. Effect of blood pressure during the acute period of ischemic stroke on stroke outcome: a tertiary analysis of the GAIN international trial. Stroke. 2003;34:2420-5. (Pubitemid 37221954)
28. Aslanyan S, Weir CJ, Lees KR, GAIN International Steering Committee and Investigators. Elevated pulse pressure during the acute period of ischemic stroke is associated with poor stroke outcome. Stroke. 2004;33:153-5.
29. Jensen MB, Yoo B, Clarke WR, Davis PH, Adams Jr HR. Blood pressure as an independent prognostic factor in acute ischemic stroke. Can J Neurol Sci. 2006;33:34-8.
30. Okumura K, Ohya Y, Maehara A, Wakugami K, Iseki K, Takishita S. Effects of blood pressure levels on case fatality after acute stroke. J Hypertens. 2005;23:1217-23. (Pubitemid 40862726)
31. • Sandset EC, Bath PM, Boysen G, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet. 2011;377(9767):741-50. 2029 patients with acute stroke and SBP > 140mmHg were allocated to candesartan or placebo. In contrast to other recent trials (CHIPPS), therewas no indication that careful bloodpressure lowering treatment with the angiotensin-receptor blocker candesartan is beneficial in patients with acute stroke and raised blood pressure. If anything, the evidence suggested a harmful effect.
32. Robinson TG, Potter JF, Ford GA, et al. Effects of antihypertensive treatment after acute stroke in the continue or stop post-stroke antihypertensives collaborative study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol. 2010;9(8):767-75.
33. Potter JF, Robinson TG, Ford GA, et al. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol. 2009;8(1):48-56.
34. Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators. Magnesium for treatment of acute lacunar stroke syndromes. Lancet. 2004;363:439-45.
35. Wahlgren NG, MacMahon DG, De Keyser J, Indredavik B, Ryman T. Intravenous Nimodipine west European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebrovasc Dis. 1994;4:204-10.
36. Barer DH, Cruickshank JM, Ebrahim SB, Mitchell JR. Low dose beta blockade in acute stroke ("BEST" trial): an evaluation. Br Med J. 1988;296:737-41. (Pubitemid 18066502)
37. • He J, Zhang Y, Xu T, et al, for the CATIS investigators. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischaemic stroke. JAMA. 2014;311(5):479-489. doi:10.1001/jama.2013. 282543. The most recently published large trial of blood pressure reduction in ischemic stroke, in which 4071 patients with acute stroke and elevated SBP were randomized to antihypertensive treatment (with the aim of lowering SBP by 10 to 25% in 24 hours), or to discontinue all antihypertensive medications. BP reduction did not reduce the likelihood of death or major disability at 14 days.
38. Schrader J, Lüders S, Kulschewski A, et al. The ACCESS study: evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke. 2003;34(7):1699-703.
39. Bath PMW, Martin RH, Palesch Y, et al. Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis. Stroke. 2009;40(11):3541-6.
40. Astrid G, Hornslien M, on Behalf of the Scandinavian Candesartan Acute Stroke Trial Study Group, et al. Effects of candesartan in acute stroke on cognitive function and quality of life: results from the scandinavian candesartan acute stroke trial. Stroke. 2013;44:2022-4.
41. Bath PMW. Efficacy of nitric oxide in stroke (ENOS) trial: summary of protocol (version 1.5). http://www.enos.ac.uk/enossummaryv15.htm. Updated 2007. Accessed 21 October 2013.
42. Geeganage C, Bath PMW. Vasoactive drugs for acute stroke. Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No.: CD002839. doi:10.1002/14651858.CD002839.pub2.
43. Lawes CMM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke. 2004;35(3):776-85. (Pubitemid 38280858)
44. The Blood Pressure in Acute Stroke Collaboration. Vasoactive drugs for acute stroke. Cochrane Database of Systematic Reviews 2000, Issue 4. Art. No.: CD002839. doi:10.1002/14651858.CD002839.
45. Bath P. International society of hypertension (ISH): statement on the management of blood pressure in acute stroke. J Hypertens. 2003;21:665-72.
46. Adams HP, del Zoppo G, Alberts MJ, et al. Guidelines for the earlymanagement of adultswith ischemic stroke: a guideline from the American Heart Association/American Stroke Association stroke council, clinical cardiology council, cardiovascular radiology and intervention council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups: the American academy of neurology affirms the value of this guideline as an educational tool for neurologists. Circulation. 2007;115(20):e478-534.
47. Jauch EC, Saver JL, Adams HP, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870-947.
48. Anderson C. Enhanced control of hypertension and thrombolysis stroke study (ENCHANTED). http://clinicaltrials.gov/show/NCT01422616. Updated 2013. Accessed 21 October 2013.
49. Saposnik G, Del Brutto OH, for the Iberoamerican Society of Cerebrovascular Diseases. Stroke in south America: a systematic review of incidence, prevalence, and stroke subtypes. Stroke. 2003;34(9):2103-7. (Pubitemid 37107334)
50. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003;2(1):43-53. (Pubitemid 37443343)
51. Zhang Y, Reilly K, Tong W, et al. Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China. J Hypertens. 2008;26:1446-52.
52. Ohwaki K, Yano E, Nagashima H, Hirata M, Nakagomi T, Tamura A. Blood pressuremanagement in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke. 2004;35(6):1364-7. (Pubitemid 38697459)
53. Robinson TG, Potter JF. Blood pressure in acute stroke. Age Ageing. 2004;33(1):6-12. (Pubitemid 38111442)
54. Rodriguez-Luna D, Piñeiro S, Rubiera M, et al. Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage. Eur J Neurol. 2013;20(9):1277-83.
55. Jauch EC, Lindsell CJ, Adeoye O, Khoury J, Barsan W, Broderick J. Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke. 2006;37:2061.
56. Butcher KS, Jeerakathil T, Hill M, et al. The intracerebral haemorrhage acutely decreasing arterial pressure trial. Stroke. 2013;44:620-626.
57. Willmot M, Leonardi-Bee J, Bath PMW. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension. 2004;43(1):18-24. (Pubitemid 38031905)
58. Vemmos KN, Tsivgoulis G, Spengos K, Zakopoulos N, Synetos A. U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J Intern Med. 2004;255:257-65. (Pubitemid 38241370)
59. Intercollegiate Stroke Working Party. National clinical guideline for stroke. 4th ed. London: Royal College of Physicians; 2012.
60. •• Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355-65. This large trial of intensive BP lowering versus standard guideline care in patients with acute ICH and elevated SBP, showed borderline significant reduction in poor outcome at 90-days, defined by death or major disability, with a significant favorable shift in an ordinal analysis of the distribution of scores on the modified Rankin Scale in the intensive treatment group. Furthermore, intensive BP reduction was shown to be safe and to result in significantly better health-related quality of life. Effects were consistant across different patient and disease characteristics.
61. Qureshi A. Antihypertensive treatment of acute cerebral hemorrhage (ATACH): rationale and design. Neurocrit Care. 2007;6:56-66. (Pubitemid 46424454)
62. Powers WJ, Zazulia AR, Videen TO, Adams RE, Yundt KD, Aiyagari V. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology. 2001;57:18-24. (Pubitemid 32634845)
63. Qureshi AI, Mohammad YM, Yahia AM, Suarez JI, Siddiqui AM. A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. J Intensive Care Med. 2005;20:44-52.
64. Qureshi AI, Bliwise DL, Bliwise NG, Akbar MS, Uzen G, Frankel MR. Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model. Crit Care Med. 1999;27:480-5. (Pubitemid 29162666)
65. Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7(5):391-9.
66. Vaughan C, Delanty N. Hypertensive emergencies. Lancet. 2000;356:411-7. (Pubitemid 30487503)
67. Hinchey J, Chaves C, Appignani B. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1999;52:1497-500.
68. Pearce C, Wallin J. Labetalol and other agents that block both alpha and beta adrenergic receptors. Cleve Clin J Med. 1994;61:59-69. (Pubitemid 24053928)
69. Rose J, Mayer S. Optimising blood pressure in neurological emergencies. Neurocrit Care. 2004;1:287-99. (Pubitemid 41278343)
70. Neutel J, Smith D, Wallin D, et al. A comparison of intravenous nicardipine and sodium nitroprusside in the immediate treatment of severe hypertension. Am J Hypertens. 1994;7:623-8. (Pubitemid 24265158)
71. Steiner T et al. European stroke organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis. 2013;35:93-112.
72. King Jr JT. Epidemiology of aneurysmal subarachnoid hemorrhage. Neuroimaging Clin N Am. 1997;7:659-68.
73. Hop J, Rinkel GJ, et al. Case fatality rates and functional outcome after sud-arachnoid haemorrhage: a systematic review. Stroke. 1997;28:660-4. (Pubitemid 27118394)
74. Qureshi AI, Suri MF, Yahia AM, Suarez JI, Guterman LR, Hopkins LN. Risk factors for subarachnoid hemorrhage. Neurosurgery. 2001;49:607-12.
75. Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2007;38(8):2315-21. (Pubitemid 47457575)
76. Gomis P, Rousseaux P, Johy D, et al. Initial prognostic factors of aneurysmal subarachnoid haemorrhage. Neurochirurgie. 1994;40:18-30. (Pubitemid 24124085)
77. Duran L, Balci K, et al. Has admission blood pressure any prognostic value in patients with subarachnoid haemorrhage: an emergency department experience. J Clin Hypertens. 2013;15:737-41.
78. Wartenberg KE. Update on the management of subarachnoid hemorrhage. http://www.medscape.com/viewarticle/780438-3. Updated 2013. Accessed 21 October 2013.
79. Wijdicks EFM, Vermeulen M, Murray GD, Hijdra A, van Gijn J. The effects of treating hypertension following aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg. 1990;92(2):111-7. (Pubitemid 20165037)
80. Ohkuma H, Tsurutani H, Suzuki S. Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke. 2001;32(5):1176-80. (Pubitemid 32825805)
81. Naidech AM, Janjua N, Kreiter KT, et al. Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol. 2005;62(3):410-6. (Pubitemid 40349476)
82. Fujii Yet al. Ultra early rebleeding in sub arachnoid haemorrhage. J Neurosurg. 1996;84:35-42.
83. Budohoski KP, Czosnyka M, Kirkpatrick PJ, Smielewski P, Steiner LA, Pickard JD. Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage. Nat Rev Neurol. 2013;9:152-63.
84. Adams HP. Early management of aneurysmal subarachnoid hemorrhage: a report of the cooperative aneurysm study. J Neurosurg. 1981;54:141-5.
85. Tomer JC, Nibbelink DW, Burmeister LF. Statistical comparisons of end results of a randomized treatment study. In: Sans AL, Nibbelink DW, Tomer JC, editors. Aneurysmal subarachnoid hemorrhage: report of the cooperative study. Baltimore, Md: Urban & Schwarzenberg; 1981. p. 249-276.
86. Hasan D, Vermeulen M, Wijdicks EF, Hijdra A, van Gijn J. Effect of fluid intake and antihypertensive treatment on cerebral ischemia after subarachnoid hemorrhage. Stroke. 1989;20(11):1511-5. (Pubitemid 19278138)
87. Bederson JB, Connolly Jr ES, Batjer HHM, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the stroke council, American Heart Association. Stroke. 2009;40(3):994-1025.
88. Ducros A, Boukobza M, Porcher R, et al. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007;130:3091-101. (Pubitemid 350209073)
89. Lu S, Liao Y, Fu JL, et al. Nimodipne for treatment of primary thunderclap headache. Neurology. 2004;62:1414-6. (Pubitemid 38526061)
90. Chen SP, Fuh JL, Wang S. Reversible cerebral vaoconstriction syndrome: an under-recognised clinical emergency. Neurol Disord. 2010;3(3):161-71.
91. Bouchard M, Verreault S, et al. Intra-arterial milrinone for reversible cerebral vasoconstrictor syndrome. Headache. 2009;49:142-5.
92. Lund-Johansen P. Pharmacology of combined alpha and beta blockade. Haemodynamic effects of labetalol. Drugs. 1984;28:35-50. (Pubitemid 15192242)
93. Olsen K, Svendsen L, Lasen F, Paulson O. Effect of labetalol of cerebral blood flow, oxygen metabolism and autoregulation in healthy humans. Br J Anaesth. 1995;75:51-4.
94. Marek P, Varon J. Hypertensive crises: challenges and management. Chest. 2007;131:1949-62. (Pubitemid 46981658)
95. Lui-DeRyke X, Janisse J, Coplin W, et al. A comparison of nicardipine and labetalol for acute hypertension management following acute stroke. Neurocrit Care. 2008;9:167-76.
96. Lui-DeRyke X, Parker Jnr D, Levy P, et al. A prospective evaluation of labetalol versus nicardipine for acute hypertension management following stroke. Crit Care Med. 2009;37(suppl):161.
97. Malesker M, Kondrack R, et al. Nicardipine in the management of hypertension in critically ill patients. Chest. 2009;136(No.4-MeetingAbstracts): 43S. doi:10.1378/chest.136.4-MeetingAbstracts.43S-a.
98. Freiderich J, Butterworth J. Sodium nitroprusside: twenty years and counting. Anaesth Analg. 1995;81:152-62.
99. Rodrigues G, Varon J. A unique agent for the critical care practitioner: clevidipine. Crit Care Shock. 2006;9:37-41. (Pubitemid 43871195)
100. Pollock C, Varon J, et al. Clevidipine is safe and effective for treatment of patients with acute severe hypertension. Ann Emerg Med. 2009;53:329-38.
101. Aronson S, Dyke C, et al. The ECLIPSE trials: comparitive studies of clevidipine to nitroglycerine, sodium nitroprusside and nicardipine for treatment of acute hypertension in cardiac surgery patients. Anaesth Analg. 2008;107:1110-21.
102. • Graffagnino C, Bergese S, Love J, Schneider D, et al. Clevidipine rapidly and safely reduces blood pressure in acute intracerebral haemorrhage: the ACCELERATE trial. Cerebrovasc Dis. 2013;36(173):180. This pilot study is the first to evaluate the safety and efficacy of clevidipine for rapid BP control in ICH. Clevidipine was effective and safe. Furthermore, patients showed minimal haematoma expansion which may warrant further investigation, particularly given ongoing uncertainty surrounding the effect of BP on hematoma growth in ICH.
103. Bath PMW, Wilmot M, et al. Nitric oxide donors, L arginine or nitric oxide synthase inhibitors for acute stroke. Cochrane Database Syst Rev. 2002;4, CD001928.
104. Cherney D, Straus S. Management of patients with hypertensive urgencies and emergencies. A systematic review of the literature. J Gen Intern Med. 2002;17(12):937-45. (Pubitemid 35471992)
105. Hirschl MM, Binder M, Bur A, Herkner H, Müllner M, Woisetschläger C, et al. Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies. Intensive Care Med. 1997;23(8):885-8. (Pubitemid 27417693)
106. Buch J. Urapidil, a dual-acting antihypertensive agent: current usage considerations. Adv Ther. 2010;27(7):426-33.